Literature DB >> 9879965

Granulocytic ehrlichiosis: an emerging or rediscovered tick-borne disease?

N H Ogden1, Z Woldehiwet, C A Hart.   

Abstract

The Ehrlichieae are gram-negative obligately intracellular bacterial pathogens. They can be divided into at least three genogroups on the basis of 16S rRNA gene sequences, but are also classified by target cell specificity. A group of granulocytic ehrlichiae primarily infect neutrophils and fall into genogroup II. The granulocytic ehrlichiae are subdivided by their target hosts, i.e., Ehrlichia phagocytophila in cattle and sheep, E. equi in horses, and the agents of human (HGE) and llama (LGE) granulocytic ehrlichioses. However, these subdivisions may give a false impression, as all these species are closely related both antigenically and on the basis of 16S rRNA operon sequence. In addition, cross-species transmission can occur naturally or by experimental infection. The vectors for these granulocytic ehrlichiae are hard-bodied ixodid ticks, and the reservoir hosts are probably wild rodents, deer and sheep. In each host, this illness presents as a febrile disease which can be followed by immunosuppression leading to secondary infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879965     DOI: 10.1099/00222615-47-6-475

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  15 in total

1.  A case of ovine tick-borne fever in December in Norway.

Authors:  S Stuen; E O Engvall; B Brändström; J Slettebø
Journal:  Acta Vet Scand       Date:  1999       Impact factor: 1.695

2.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Jason A Carlyon; Ji-Lian Cai; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Defective phagocytosis in Anaplasma phagocytophilum-infected neutrophils.

Authors:  Justin W A Garyu; Kyoung-seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Structure of the expression site reveals global diversity in MSP2 (P44) variants in Anaplasma phagocytophilum.

Authors:  Anthony F Barbet; Anna M Lundgren; A Rick Alleman; Snorre Stuen; Anneli Bjöersdorff; Richard N Brown; Niki L Drazenovich; Janet E Foley
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

6.  Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis.

Authors:  M Akkoyunlu; S E Malawista; J Anguita; E Fikrig
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States.

Authors:  Max Maurin; Johan S Bakken; J Stephen Dumler
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

8.  Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes.

Authors:  Jinho Park; Kyoung Seong Choi; J Stephen Dumler
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum.

Authors:  A F Barbet; P F M Meeus; M Bélanger; M V Bowie; J Yi; A M Lundgren; A R Alleman; S J Wong; F K Chu; U G Munderloh; S D Jauron
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Borrelia burgdorferi sensu lato, Anaplasma phagocytophilum, Francisella tularensis and their co-infections in host-seeking Ixodes ricinus ticks collected in Serbia.

Authors:  Marija Milutinović; Toshiyuki Masuzawa; Snezana Tomanović; Zeljko Radulović; Takashi Fukui; Yoshihiro Okamoto
Journal:  Exp Appl Acarol       Date:  2008-06-13       Impact factor: 2.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.